Oral low-dose cyclophosphamide in metastatic hormone refractory prostate cancer (MHRPC)

Autor: Nicolini, A *, Mancini, PA, Ferrari, P, Anselmi, L, Tartarelli, G, Bonazzi, V, Carpi, A, Giardino, R
Zdroj: In Biomedicine & Pharmacotherapy 2004 58(8):447-450
Databáze: ScienceDirect